BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FBXW7, AGO, 55294, ENSG00000109670, FLJ11071, SEL-10, CDC4, FBXW6, SEL10, FBW7, DKFZp686F23254, FBX30
1476 results:

  • 1. Medical Advocacy among Latina Women Diagnosed with breast cancer.
    Torres P; Guitelman J; Lucio A; Rini C; Molina Y
    Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673406
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical characteristics, proteins, and genes related to interstitial pneumonia-associated squamous cell carcinoma of the lungs.
    Mochizuki A; Nishida H; Kaimori R; Kondo Y; Kadowaki H; Kusaba T; Kawamura K; Osoegawa A; Sugio K; Daa T
    Pathol Res Pract; 2024 May; 257():155292. PubMed ID: 38657559
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Implementation of a Mindful Walking Intervention in breast cancer Patients After Their Primary Oncologic Treatment: Results of a Qualitative Study Within a Randomized Controlled Trial.
    Ortiz M; Schröder ML; Brinkhaus B; Stöckigt B
    Integr Cancer Ther; 2024; 23():15347354241237972. PubMed ID: 38654515
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inflammatory breast cancer: Epidemiologic data and therapeutic results.
    Boussen H; Berrazaga Y; Sherif Kullab ; Manai M; Berrada N; Mejri N; Siala I; Levine PH; Cristofanilli M
    Int Rev Cell Mol Biol; 2024; 384():1-23. PubMed ID: 38637094
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation.
    Park S; Ryu WJ; Kim TY; Hwang Y; Han HJ; Lee JD; Kim GM; Sohn J; Kim SK; Kim MH; Kim J
    Exp Mol Med; 2024 Apr; 56(4):987-1000. PubMed ID: 38622197
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. There and Back Again: A Perspective on 20 Years of CYP4Z1.
    Kowalski JP; Rettie AE
    Drug Metab Dispos; 2024 May; 52(6):498-507. PubMed ID: 38604728
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Purification and biochemical characterization of the G4 resolvase and DNA helicase FANCJ.
    Kulikowicz T; Sommers JA; Fuchs KF; Wu Y; Brosh RM
    Methods Enzymol; 2024; 695():1-27. PubMed ID: 38521581
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The fbxw7-binding sites on FAM83D are potential targets for cancer therapy.
    Jiang X; Wang Y; Guo L; Wang Y; Miao T; Ma L; Wei Q; Lin X; Mao JH; Zhang P
    Breast Cancer Res; 2024 Mar; 26(1):37. PubMed ID: 38454442
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Progress in site-specific cancer mortality in Canada over the last 70 years.
    Warkentin MT; Ruan Y; Ellison LF; Billette JM; Demers A; Liu FF; Brenner DR
    Sci Rep; 2024 Mar; 14(1):5688. PubMed ID: 38454087
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.
    Treekitkarnmongkol W; Solis LM; Sankaran D; Gagea M; Singh PK; Mistry R; Nguyen T; Kai K; Liu J; Sasai K; Jitsumori Y; Liu J; Nagao N; Stossi F; Mancini MA; Wistuba II; Thompson AM; Lee JM; Cadiñanos J; Wong KK; Abbott CM; Sahin AA; Liu S; Katayama H; Sen S
    Sci Signal; 2024 Mar; 17(826):eadh4475. PubMed ID: 38442201
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Filgrastim biosimilar (EP2006): A review of 15 years' post-approval evidence.
    Gascón P; Harbeck N; Rapoport BL; Anderson R; Brueckmann I; Howe S; Aapro M
    Crit Rev Oncol Hematol; 2024 Apr; 196():104306. PubMed ID: 38401695
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Surgical Management and System Therapy of the Most Giant Known Malignant Metastatic breast Phyllodes Tumor: A Case Report and Review of the Literature.
    Kaiser C; Abramian AV; Faridi A
    Oncol Res Treat; 2024; 47(4):145-148. PubMed ID: 38382477
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now.
    de Ligt KM; Koppert LB; de Rooij BH; van de Poll-Franse LV; Velikova G; Cardoso F
    Breast; 2024 Apr; 74():103676. PubMed ID: 38359564
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02).
    Phillips C; Pinkham MB; Moore A; Sia J; Jeffree RL; Khasraw M; Kam A; Bressel M; Haworth A
    Breast; 2024 Apr; 74():103675. PubMed ID: 38340685
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The reunion with my patients: their journey and experience 30 years after their intervention for adolescent idiopathic scoliosis via CD instrumentation.
    Pérez-Grueso FJS; Moreno-Manzanaro L; Pizones J
    Spine Deform; 2024 May; 12(3):671-679. PubMed ID: 38305991
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [A Case of Postoperative Recurrence of Bilateral breast cancer in Which Stable Disease Condition Was Achieved by Olaparib].
    Terakawa H; Kawata C; Kurokawa Y; Ooe Y; Mohri R; Hirata M; Moriyama H; Kinoshita J; Kawashima H; Inaki N
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1414-1416. PubMed ID: 38303292
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Recurrent breast cancer with Bone Metastasis Effectively Treated with Abemaciclib plus Endocrine Therapy-A Case Report].
    Adachi K; Nagae J; Kubota H; Suzuki S; Hirano T; Sakurai K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1845-1847. PubMed ID: 38303227
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Laparoscopic Abdominoperineal Resection of the Rectum in a Case with Pagetoid Spread of Anal Canal Carcinoma].
    Yabe N; Kamata A; Takenoya T; Harada Y; Kondo A; Asada Y; Sako H; Oto I; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Futei Y; Ishii Y; Watanabe M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1756-1758. PubMed ID: 38303197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [A Case of Giant Phyllodes Tumor Treated with breast Reconstruction].
    Tatara N; Yoshitomi S; Morikawa N; Hara K; Tsuji H
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1733-1735. PubMed ID: 38303189
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.
    Khan AJ; Man S; Abbas M; Liu S; Zhang F
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130577. PubMed ID: 38301858
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 74.